One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Soft Tissue Allografts Market

[ 英語タイトル ] Soft Tissue Allografts Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0082888
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Allergan Plc
- B. Braun Melsungen AG
- Conmed Corporation
- Xtant Medical Holdings, Inc.
- Becton Dickinson and Company
- Arthrex, Inc.
- Bone Bank Allografts
- Osiris Therapeutics, Inc.
- Integra LifeSciences Corporation
- Stryker Corporation

[Report Description]

The rising demand for Soft Tissue Allografts in athletics & other sports is contributing largely to the market growth. Modern training regimens in athletics, field events, and a number of other contact sports like American football, require athletes to undergo intensive training sessions which are in practice more strenuous than the actual sport itself.

High-intensity training regimens are directly correlated with athletic performance improvement but excessive training also induces muscle and bone fatigue and often leads to injury. Consequently, injury prevalence among athletes has been increasing especially due to excessive training. The competitive nature of sports has spurred the demand among athletes for quick recovery and easily accessible modalities to treat musculoskeletal injuries. As a result, the demand for soft tissue allografts has been increasing in athletics and other contact sports, which in turn is fuelling the growth of the global soft tissue allografts market.

Key Market Trends

Dentistry is Expected to Witness a Healthy Growth Over the Forecast Period

In countries such as India, Australia, the United States, etc., more attention is given to the aesthetics and this results in rising aesthetic procedures. Dentistry is the sector which is currently witnessing a large number of aesthetic procedures to improve dental appearance.

Along with that, dental disorders such as Periodontitis are also on the rise. For instance, the National Institute of Health has stated that periodontitis is affecting around 20-50% of the global population. Also, NIH has stated that around 44% of the people aged 65 and more are prone to have periodontal disease. Therefore, the need for proper treatment has increased.

The soft tissue allografts are used to stop the gum recession and to improve the appearance of the same. Along with the improved gum aesthetics, soft tissues are also beneficial in curing periodontal disease which is augmenting the demand for the same across the globe. hence, it is indicated that the dentistry segment will show satisfactory growth over the forecast period.

North America is Expected to Dominate the Market

The global soft tissue allografts market has been segmented into five major regions, viz. North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Driven by the United States, North America is expected to dominate the market in the coming future. This is majorly due to factors such as increasing prevalence of diabetic foot ulcers, better healthcare awareness programs for diabetes, and an increase in a number of surgical procedures on anterior cruciate ligament (ACL). Furthermore, technological development in dental implants and increasing expenditure by major & small key players for the development of soft tissue allografts are also boosting the growth of the market studied in the North America region.

Competitive Landscape

The soft tissue allografts market is moderately competitive and many of the global players are into the market. For instance, Allergan Plc., B. Braun Melsungen AG, Conmed Corporation, etc. are providing these products across the globe. Also, new product launches from these players are augmenting the demand for these products.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Cases of Orthopedics and Dentistry Related with Aging
4.2.2 Increasing Demand for Soft Tissue Allografts in Athletics and Other Sports
4.2.3 Advancements in Soft Tissue Replacement
4.3 Market Restraints
4.3.1 High Cost of Treatment
4.3.2 Complicated Reimbursement Policies
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 Cartilage Allograft
5.1.2 Tendon Allograft
5.1.3 Meniscus Allograft
5.1.4 Dental Allograft
5.1.5 Others
5.2 By Application
5.2.1 Orthopedic
5.2.2 Dentistry
5.2.3 Wound Care
5.2.4 Others
5.3 By End-User
5.3.1 Hospitals
5.3.2 Aesthetic Centres
5.3.3 Orthopedic Clinics
5.3.4 Dental Clinics
5.3.5 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Allergan Plc
6.1.2 B. Braun Melsungen AG
6.1.3 Conmed Corporation
6.1.4 Xtant Medical Holdings, Inc.
6.1.5 Becton Dickinson and Company
6.1.6 Arthrex, Inc.
6.1.7 Bone Bank Allografts
6.1.8 Osiris Therapeutics, Inc.
6.1.9 Integra LifeSciences Corporation
6.1.10 Stryker Corporation




Recommended reports